Li Ka-Shing-Sponsored Hutchmed Sells Stake in Unit for $608 Million
(Bloomberg) — Biopharmaceutical company Hutchmed China Ltd., subsidized by way of Hong Kong billionaire Li Ka-shing, noticed its stocks rally on Thursday morning after saying it’ll divest stocks in a three way